Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy

Zhen Qu1, Gang Liu, Jun Li

  • 1Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.

Abstract

Insights

Absence of glomerular IgG4 deposition helps differentiate malignancy-associated membranous nephropathy (M-MN) from idiopathic membranous nephropathy (I-MN). This finding, along with older age and specific lab markers, aids in distinguishing these conditions.

Area of Science:

  • Nephrology
  • Immunopathology
  • Oncology

Background:

  • Malignancy-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN) share similar renal pathological features.
  • Glomerular IgG4 deposition is implicated in the pathogenesis of I-MN.
  • Distinguishing between M-MN and I-MN is clinically important.

Purpose of the Study:

  • To compare IgG subclass immune complex deposition between M-MN and I-MN patients.
  • To analyze clinical and pathological data differentiating M-MN from I-MN.
  • To identify predictors for malignancy in membranous nephropathy.

Main Methods:

  • Retrospective analysis of 8 M-MN and 42 I-MN patients diagnosed between 1997-2009.
  • Immunohistochemistry used to detect glomerular IgG subclass deposition.
  • Comparison of clinical and pathological data between the two groups.

Main Results:

  • M-MN patients were older with lower serum albumin and higher C-reactive protein (CRP) levels compared to I-MN patients.
  • M-MN cases showed earlier pathological stages and less glomerular IgG deposition.
  • Absence of glomerular IgG4 deposition was significantly more common in M-MN (7/8) than I-MN (6/42) and predicted malignancy.

Conclusions:

  • Absence of glomerular IgG4 deposition is a key differentiator between M-MN and I-MN.
  • Older age, severe hypoalbuminemia, and high serum CRP levels are additional clues for M-MN.
  • These findings can aid in the clinical differentiation of M-MN from I-MN.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...